WHO WE ARE
Revolutioniser of personalised medicine
GO-Dx Singapore operates a medical diagnostics and diagnostics technology business in Singapore (Business) focused on pioneering biomedical technology in rapid diagnostics, leveraging artificial intelligence and data analytics to empower individuals with personalised and effective healthcare products and solutions.
The Business is focused on providing diagnostic testing and analysis services and the sale and distribution of nutraceutical products.
Our purpose
To deliver cutting-edge and proprietary technology in rapid diagnostics, leveraging artificial intelligence and data analytics to empower individuals with personalised and effective healthcare solutions, ultimately promoting health and wellness for all of humanity.
Our Mission
To transform the field of diagnostics and wellness by building an ecosystem that leverages the power of molecular pathology, microbiome immunology, health data, and artificial intelligence. We envision a future where every individual has access to personalised and accurate health information, enabling them to make informed decisions about their health and wellness. Our goal is to develop innovative solutions that not only diagnose but also prevent diseases, providing better health outcomes for all of humanity.
How we do it
Through collaboration with experts in these fields, we strive to push the boundaries of what is possible, driving progress and advancements that benefit society as a whole. We are committed to providing exceptional service to our clients and partners, utilizing our expertise and technology to deliver accurate and timely diagnostic information. At GO-Dx, we are dedicated to improving the health and well-being of individuals and communities worldwide, and we are proud to be at the forefront of this important work.
Products and Services
The Products include the products which the Company has rights to distribute in various Asian territories including
• “G’Nest Deluxe” and “G’Nest Premium” products manufactured and supplied by FEGO Biotech Pte Ltd;
and
• “C’Neuros” product manufactured and supplied by NGF Bioenterprise Pte Ltd (Products Range).
The Services include diagnostic testing and analysis services including:
• RNA mining/mapping & analytics platform
• Neurological and immunological precision medicine via proprietary genetic and epigenetic screening
Plus services currently in research and development phase, and planned for future commercialisation:
• miRNA-based early screening tests for various cancers and diagnostic platforms
• Chronic/infectious disease prediction via proprietary DNA profiling and fluorescence in situ hybridisation (FISH) platforms
• Liquid biopsy based diagnostics for cancers using NGS technology
• Al-enabled platform (Services Range)
Meet our Management Team
Our success lies in years of experience in biotechnology, biopharmaceutical, healthcare, venture capital industry.
Dr Lim Kah Meng
Chief Executive Officer
Experienced scientist in the biotechnology and biopharmaceutical industry
Started his career as a Research Scientist in A*Star and as a Professor in NTU before venturing as an entrepreneur and advisor to several biotech companies
Currently serving as Independent Director in a SGX listed company and Board director in several other biotech companies
Holds Ph.D. in Biomedicine from National University of Singapore
Danny Heng
Chief Financial Officer
Extensive experience as Group CFO in listed companies and private equity firms.
Proven track record in enhancing shareholders’ value by improving effectiveness and efficiency of financial and management functions.
Holds B.BA. from City University of New York, USA and M.S. (Accountancy & Info-System Management) from Pace University, New York, USA.
FCA, CPA, CA, FCArb.
Dr Ron Tan
Chief Scientific Officer
More than 17 years experience in clinical diagnostics innovation.
Holds 2 international patents and 2 proprietary know-hows, and has 35 scientific publications internationally.
Holds Ph.D. in Biomedical Science from National University of Singapore.
Board of Directors
Dr Lim Kah Meng
Group Managing Director / Executive DirectorScientist and experienced serial entrepreneur in the biotech & biopharma industry | Former A*Star researcher and professor in Nanyang Technology University of Singapore | Founder of GO-Dx Corporation | Board member of a Singapore listed biotech company
Lim Sah Soon
Executive DirectorChartered Surveyor and Chartered Secretary | Currently serving as Managing Director of charity organisation, Huaxia Cultural Hub Ltd | Also serves as a Director of two family companies, The Kindred Spirit Pte Ltd and Pheng Geck Pte Ltd | From 1978 to 1994, served as a Super-Scale Officer in Housing and Development Board, Prime-Minister Office, Ministry of Community Development and Singapore People Association | Appointed as Secretary General for the Singapore Chinese Chamber of Commerce & Industry (SCCCI) as well as the Honorary Secretary General of the then Singapore Federation of Chambers of Commerce & Industry from 1995 to 2013 | Since retirement from SCCCI in 2013, has served as a Member of the Practicing Management Consultants Certification Board in Singapore | Also chairs the Membership Affairs Committee of the Singapore Teochew Federation | Also serves as Council Member of TeoAnn Huey Kuan, Member of the TCM Board Disciplinary Investigation Panel, Advisor to World Lin Chamber of Commerce, and Advisor to Federation of World Cultural & Art Society | Conferred by the President of Singapore with PPA(P) & PPA(G), and was awarded the World Chinese Model
Matthew Leonard
Independent / Non-Executive DirectorAccomplished business professional with significant experience working in both Australia and Singapore | Has over 12 years of outstanding record of achievement in demanding, complex and highly competitive markets | Possesses expertise across advertising, marketing and media event management sector, with recent focus on linking opportunities with high-net-worth individuals throughout Asia | A member of Golden Venture Capital Pty Ltd, an Australian company which provides corporate advisory and consultancy services throughout Australia and international markets (assisted a number of companies with capital raising transactions throughout Asia and Australia) | Currently an Executive Director of BPH Global Ltd (ASX:BP8), an Asia-Pacific plant-based biotechnology company, with his role being focused on business operations and business development | Is also a Non-Executive Director of Agri Skylight Ltd (NSX:AGS)
Justyn Stedwell
Independent / Non-Executive DirectorOver 15 years’ experience acting as an outsourced Company Secretary for ASX listed
companies within various industries | Assisted Lightning Minerals Ltd (ASX:L1M) through their successful IPO on the ASX in his capacity as Company Secretary | Currently the Company Secretary of Spenda Limited (ASX:SPX) | Previously Company Secretary of former ASX top 200 company Imugene Limited (ASX:IMU) for approximately 10 years | Has also served as a Non-Executive Director on several ASX listed company Boards | Completed a Bachelor of Commerce (Management & Economics) at Monash University, Graduate Diploma of Accounting at Deakin University and is a graduate of the Governance Institute of Australia | Sold his outsourced company secretary business with approximately 20 listed clients to Automic Group in 2021